Events

Automation and Instrumentation in the Chemical Industry (Part 1) Presented by International Society of Automation (ISA) & ACS

Automation and Instrumentation in the Chemical Industry (Part 2) Presented by International Society of Automation (ISA) & ACS  

Careers in Chemistry Panel Discussion Panel Members: Elizabeth Tinapple – SEA Ltd. Kevin McGarry – Andelyn Biosciences Rob Camm – Owens Corning Mary’beth Ramey  – DuPont Marciano Bagnoli – Georgia Pacific

ACS President-elect Prof. Angela K Wilson (Michigan State) – Recognition of 50-, 60-, and 70-year ACS section members Pathways, Progress, and the Future of the Chemical Enterprise Today is a day of celebration – the recognition of its long-time members by the Columbus ACS section.  To achieve these recognitions, there has been a pathway – sometimes short, sometimes long – but, nonetheless, a pathway that has been influenced by many others.  As we look ahead, it is the same type of influences that enable awards that will impact the future of the chemical sciences.  This future is built upon so many factors, from drawing more people into our field and inspiring innovation, to garnering greater investments in science.  ACS, nationally and locally, as well as all of us, as individuals, have the opportunity to make a difference.  Today, we have even more ways to impact and influence than ever.  I shall discuss some of these opportunities and the future of the chemical enterprise.

Dr. Michael Wernke (S-E-A Limited) – Recognition of 50-, 60-, and 70-year ACS section members Bio: Dr. Wernke is S-E-A’s Senior Toxicologist and Pharmacologist.  He has over thirty years of experience in the areas of human health toxicology and risk assessment, exposure assessment, risk communication, and strategic planning.  He is also a licensed (Ohio) pharmacist.  Throughout his career Dr. Wernke has thoroughly and critically evaluated the human health information, experimental data, mode of action, dose-response relationships, and pharmacokinetic/toxicokinetic data for a large number of environmental and occupational chemicals, radioactive materials, pharmaceuticals, medical devices, food and feed additives and contaminants and consumer products for private and public sector clients.  In his role at SEA, Dr. Wernke is responsible for projects requiring the determination of the presence or absence of harmful or intoxicating chemicals, testing and analyzing data for harmful contaminates in consumer products or the environment, and evaluating contributing factors in the cause and manner of death or illness.  Dr. Wernke evaluates exposure to and human health effects of microbial organisms, ethanol, drugs, metals, chemicals, gases, and other occupational and environmental chemicals. He also evaluates drug related cases including, but not limited to, intoxication, drug-related problems, hazardous drug combination or overdoses, indications and contraindication, and drug labeling and warnings.  Dr. Wernke is a graduate of the University of Cincinnati, where he earned a Bachelor of Science (Biology) degree from the McMicken College of Arts and Sciences, a Bachelor of Science degree in Pharmacy with Honors (Magna Cum Laude) from the James L. Winkle College of Pharmacy, and a Ph.D. in Toxicology and Pharmacology from the Division of Graduate Studies and Research.